Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
90
Views
1
CrossRef citations to date
0
Altmetric
Letter

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]

Leticia OrsattiBoehringer Ingelheim International GmbH, Ingelheim, Germany, [email protected]
,
Josep ForteaBoehringer Ingelheim International GmbH, Ingelheim, Germany, [email protected]
&
Manuel QuaresmaBoehringer Ingelheim International GmbH, Ingelheim, Germany, [email protected]Correspondence[email protected]
Pages 1177-1178 | Published online: 12 Apr 2019
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days
"Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]." Drug Design, Development and Therapy, , pp. 1177–1178

Disclosure

LO, JF, and MQ are employees of Boehringer Ingelheim. The authors report no other conflicts of interest in this communication.

Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.